AMRUTAJAN HEALTH Latest Share Price (AMRUTANJAN)
TODAY IN ONE LINE
AMRUTANJAN edged up 0.3% on light volume, in line with Nifty's -0.5% move.
With a market cap of ₹1,434.4 Cr., it trades at a P/E of 26.57. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
AMRUTAJAN HEALTH flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●High Capital EfficiencyROCE of 16.2% indicating pricing power
- ●Strong Return on EquityHealthy ROE of 15.6%
- ●Healthy Operating MarginsOPM is structurally strong at 15.5%
- ●Steady Dividend YieldReliable 1.50% dividend yield
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.00x
- ●FII AccumulationFII holding increased by 1.03% QoQ
- ●Positive Free Cash FlowFCF has been positive for 3 consecutive years
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Rising Receivables vs SalesReceivables grew 14.6% outpacing sales growth of 7.3%
Latest AMRUTAJAN HEALTH News
What changed recently?
Recent events, corporate actions, and announcements.
AMRUTAJAN HEALTH valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for AMRUTAJAN HEALTH, framed against the sector median so the premium or discount is obvious at a glance.
AMRUTAJAN HEALTH trades at a P/E of 26.57× and P/B of 3.87×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
AMRUTAJAN HEALTH technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for AMRUTAJAN HEALTH — derived from the latest tape, not yesterday's close.
AMRUTAJAN HEALTH last traded at ₹497 with an intraday range of ₹489.25–₹506.3 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹497.00| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 539.88 | +42.88 | +8.63% |
| R3 | 522.83 | +25.83 | +5.20% |
| R2 | 514.57 | +17.57 | +3.53% |
| R1 | 505.78 | +8.78 | +1.77% |
| PIVOT | 497.52 | 0.52 | 0.10% |
| CURRENT | 497.00 | — | — |
| S1 | 488.73 | -8.27 | -1.66% |
| S2 | 480.47 | -16.53 | -3.33% |
| S3 | 471.68 | -25.32 | -5.09% |
| S4 | 454.63 | -42.37 | -8.52% |
AMRUTANJAN is trading Below CPR, indicating Bearishness
CPR is Narrower, suggesting likely for trending moves
Day's range: ₹489.25–₹498.95
Trading Inside opening range
AMRUTAJAN HEALTH financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for AMRUTAJAN HEALTH — consolidated or standalone — with margins, YoY growth and key ratios inline.
AMRUTAJAN HEALTH reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹1,434.4 Cr. and reported EPS of ₹18.67.
AMRUTAJAN HEALTH segment analysis : revenue and profit mix.
Disclosed business segments at AMRUTAJAN HEALTH with their share of revenue and profit, switchable between consolidated and standalone reporting.
AMRUTAJAN HEALTH discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for AMRUTAJAN HEALTH.
Our AI distills the core fundamental drivers supporting AMRUTAJAN HEALTH, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
AMRUTAJAN HEALTH's investment case rests on 0 positive markers and 1 flagged concerns drawn from the latest reported filings.
What you're getting.
No strengths or opportunities on record.
Key Risks.
SWOT generation temporarily unavailable due to model error. Bedrock invocation timeout
Flip Conditions.
Valuation risk. a P/E above 35 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Return-quality risk. ROE below 11% would indicate weaker capital compounding.
Income thesis breaks if the dividend is cut or yield falls below 0.75%.
AMRUTAJAN HEALTH peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — AMRUTAJAN HEALTH is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
AMRUTAJAN HEALTH chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for AMRUTAJAN HEALTH — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
AMRUTAJAN HEALTH delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for AMRUTAJAN HEALTH over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in AMRUTAJAN HEALTH stood at 55.5% of traded volume, against a 20-day average of 59.2%.
AMRUTAJAN HEALTH announcements: results, concalls, ratings, M&A.
Filings AMRUTAJAN HEALTH sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
AMRUTAJAN HEALTH files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 64 documents below.
Updates
Amrutanjan Health Care Limited has informed the Exchange regarding 'ESG RATINGS'.
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Amrutanjan Health Care Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Trading Window
Amrutanjan Health Care Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading)…
Shareholders meeting
Amrutanjan Health Care Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 23, 2026. Further,…
Shareholders meeting
Amrutanjan Health Care Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 23, 2026
Investor decks & rating reports.
Investor Presentation
Investor Presentation
Investor Presentation
Investor Presentation
Investor Presentation
AMRUTAJAN HEALTH dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue AMRUTAJAN HEALTH has declared, sequenced by announce and record date.
AMRUTAJAN HEALTH corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
AMRUTAJAN HEALTH insider trading: promoter and management activity.
Promoter, director and designated-employee transactions in AMRUTAJAN HEALTH as reported to SEBI — buying and selling signals from the people who know the business best.
AMRUTAJAN HEALTH insider activity below tracks 1 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| S Jeyakanth | Insider | 28 May 2025 | sell | −1.4 K | ₹10.03 L | ₹716.28 |
About AMRUTAJAN HEALTH: business, sector, key facts.
What AMRUTAJAN HEALTH does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
AMRUTAJAN HEALTH operates in the Pharmaceuticals industry under the Healthcare sector, listed as NSE: AMRUTANJAN, BSE: 590006.
Amrutanjan Health Care Limited is a prominent Indian company specializing in the manufacture, supply, and sale of Ayurvedic pain relief balms and women's hygiene products. Established in 1893 and headquartered in Chennai, the company has a long history of providing healthcare solutions. Originally known as Amrutanjan Limited, it rebranded to its current name in 2007, reflecting its expansion beyond its core product line.
The company's business is segmented into three key areas: OTC (Over-the-Counter) Products, Beverages, and Others. The OTC Products segment is the largest, encompassing a wide range of pain management solutions. This includes various pain balms and roll-ons targeting different pain types (back pain, body pain, joint pain), as well as stick-on patches, gels, and sprays. Furthermore, they offer congestion management products such as cold rubs, cough syrups, nasal inhalers, and throat lozenges. Their women's hygiene product line features sanitary napkins.
Beyond pain relief and women's health, Amrutanjan also operates in the beverage sector under the Fruitnik and Fruitnik Electro+ brands, offering juice drinks. The "Others" segment encompasses a diverse array of products including corn caps, dental gel, and hand sanitizers. Interestingly, the company also manages a pain management center, demonstrating a commitment to comprehensive healthcare services.
Amrutanjan's reach extends beyond the domestic Indian market, with significant export activities to various regions globally. These export markets include the Middle East, Africa, and Southeast Asia, highlighting the international appeal of their products and brand reputation. The company's success stems from a blend of traditional Ayurvedic formulations and modern manufacturing practices, catering to a broad consumer base seeking effective and accessible healthcare solutions.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- AAREY DRUGS & PHARM (AAREYDRUGS) Share PricePeer
- AARTI DRUGS (AARTIDRUGS) Share PricePeer
- AARTI PHARMALABS (AARTIPHARM) Share PricePeer
- AJANTA PHARMA (AJANTPHARM) Share PricePeer
- AKUMS DRUGS AND PHARMA L (AKUMS) Share PricePeer
- Stocks near 52-week low (reversal watch)Screener
- Reversal Hunter strategy playbookStrategy
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
Questions investors ask about AMRUTAJAN HEALTH (AMRUTANJAN).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of AMRUTAJAN HEALTH (AMRUTANJAN)?
The current share price of AMRUTAJAN HEALTH (AMRUTANJAN) is ₹497.00. Today, the stock has gained by ₹1.65 (0.33%), trading in a range of ₹489.25 to ₹506.30. The stock opened at ₹498.95 with a trading volume of 28,162 shares.
02Is AMRUTAJAN HEALTH stock a good investment for long-term?
AMRUTAJAN HEALTH can be considered for long-term investment based on several factors. The company has a market capitalization of ₹1,434.4 Cr., P/E ratio of 26.57, ROE of 15.64%, and ROCE of 16.18%. The dividend yield stands at 1.5%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of AMRUTAJAN HEALTH stock?
The 52-week high price of AMRUTAJAN HEALTH (AMRUTANJAN) is ₹760.15, while the 52-week low is ₹476.50. Currently trading at ₹497.00, the stock is 4.3% above its 52-week low and 34.62% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy AMRUTAJAN HEALTH stock at the current price?
Whether to buy AMRUTAJAN HEALTH stock at ₹497.00 depends on multiple factors. The stock is currently trading with a P/E ratio of 26.57 and P/B ratio of 3.87. Today's performance shows a gain of 0.33%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of AMRUTAJAN HEALTH and when is the next dividend?
AMRUTAJAN HEALTH offers a dividend yield of 1.5%, which means for every ₹100 invested at the current price of ₹497.00, you can expect to receive approximately ₹1.50 annually as dividends. The face value of the stock is ₹1.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of AMRUTAJAN HEALTH?
AMRUTAJAN HEALTH's key financial metrics include: P/E Ratio: 26.57, P/B Ratio: 3.87, ROE: 15.64%, ROCE: 16.18%, Dividend Yield: 1.5%, EPS: ₹18.67, Book Value: ₹128.04, and Debt-to-Equity: 0. The company's market cap stands at ₹1,434.4 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is AMRUTAJAN HEALTH stock performing today in the market?
AMRUTAJAN HEALTH stock opened at ₹498.95 and is currently trading at ₹497.00, showing a gain of ₹1.65 (0.33%). The intraday high is ₹506.30 and low is ₹489.25. The trading volume stands at 28,162 shares, indicating moderate market participation today.
08What is the P/E ratio of AMRUTAJAN HEALTH and what does it indicate?
AMRUTAJAN HEALTH has a Price-to-Earnings (P/E) ratio of 26.57, which means investors are willing to pay 26.57 for every ₹1 of earnings. With an EPS of ₹18.67, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about AMRUTAJAN HEALTH (AMRUTANJAN) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.